By: Dr. Amrit Kaur Kaler For patients diagnosed with blood cancers such as leukemia, lymphoma, and multiple myeloma, the ...

(PRLD) stock rose after FDA cleared an early-stage trial for its blood cancer candidate PRT12396 developed with Incyte (INCY) ...

Phase 1 study of PRT12396 in patients with polycythemia vera and myelofibrosis anticipated to initiate by Q2 2026WILMINGTON, Del., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated ...

Shares of Prelude Therapeutics rose after the company said it has received Food and Drug Administration approval to proceed with a Phase 1 study for blood-cancer treatment. Shares were up 9.4% at ...

Investing.com -- Prelude Therapeutics Inc (NASDAQ:PRLD) stock jumped 7.9% on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of REGENXBIO Inc. ("Regenxbio" or "the Company") for violations of ...

Prelude Therapeutics said on Tuesday that the FDA gave clearances to proceed with early-stage trials for its experimental ...

Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) cleared ...

Ai Technology Group Inc. (OTCID:AIPG) (the “Company”) and AVM Biotechnology Inc. (“AVM”, the Washington State company that is the subject of the proposed merger) provide this joint press release. The ...

A major Lisbon hospital says it is ready to start lung cancer screening, with thousands of patients already identified.

Misinformation around menopause is still frustratingly common—among both doctors and patients. We asked experts why you ...

Nearly four out of every 10 cancer cases could be prevented if people avoided a range of risk factors including smoking, ...